Tobacco dependence is a condition in which nicotine drives repeated use and makes stopping hard. Nicotine reaches the brain quickly and triggers dopamine release, setting up a loop of craving, smoking and withdrawal. Many unsupported quit attempts end in relapse within days.
150 · 300mg
Wellbutrin contains bupropion as modified-release tablets for major depressive disorder and tobacco dependence. It is supplied in several strengths and pack sizes. You can compare the price per tablet across options.
Repeated nicotine exposure keeps the reward pathway active, so the brain comes to expect it. Missing a cigarette brings withdrawal, and relieving that discomfort reinforces further smoking. That cycle, rather than simple habit, is what makes quitting hard.
Irritability, poor concentration and strong urges to smoke are the usual difficulties. A steady routine, noting personal triggers and having a support plan in place all help, and combining these with medicine improves long-term success compared with medicine alone.
Bupropion acts on dopamine and noradrenaline pathways to reduce cravings. Treatment usually begins about a fortnight ahead of the quit date, so levels are steady by the time cravings peak. It is supplied as Wellbutrin tablets in 150 mg and 300 mg strengths, and is also used for major depressive disorder. Wider options are listed under addiction recovery. Orders are shipped to Malaysia by pharmacy partners in India in discreet packaging.
Anyone who has found earlier attempts difficult can ask a doctor or pharmacist about support. A doctor can assess whether medicine is appropriate and how it should be used alongside behavioural help.
Last updated
